All Stories

  1. Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation
  2. CD34 Expression in Low-Grade Epilepsy-Associated Tumors: Relationships with Clinicopathologic Features
  3. Letter to the Editor. Focal cortical dysplasia type IIIa and isolated hippocampal sclerosis
  4. Disseminated Oligodendroglial-like Leptomeningeal Tumor in the Adult: Case Report and Review of the Literature
  5. The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power
  6. Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients
  7. Clival chordomas: considerations after 16 years of endoscopic endonasal surgery
  8. Primary Cardiac High-grade Myxofibrosarcoma Presenting with Multiple Brain Metastases: A Case Report
  9. Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study
  10. Relationship among clinical, pathological and bio-molecular features in low-grade epilepsy-associated neuroepithelial tumors
  11. Epilepsy surgery of “low grade epilepsy associated neuroepithelial tumors”: A retrospective nationwide Italian study
  12. Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria
  13. Commentary on human adult neurogenesis across the ages: An immunohistochemical study
  14. Coexistence of meningoencephalocele and hippocampal sclerosis: a new type of dual pathology
  15. Commentary on “Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813”
  16. Suction Filter in Endoscopic Endonasal Surgery: A Technical Note
  17. Pathology-Based Approach to Seizure Outcome After Surgery for Pharmacoresistant Medial Temporal Lobe Epilepsy
  18. Erratum to: Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells
  19. Sexual dimorphism in medulloblastoma features
  20. BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas
  21. Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells
  22. Commentary on long-term seizure outcome in 211 patients with focal cortical dysplasia
  23. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology
  24. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification
  25. ACTH adenomas transforming their clinical expression: report of 5 cases
  26. About focal cortical dysplasia (FCD) type IIIa
  27. Post progression survival in glioblastoma: where are we?
  28. Commentary on IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low‐grade gliomas
  29. Expanding indications for the extended endoscopic endonasal approach to hypothalamic gliomas: preliminary report
  30. Erratum
  31. Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
  32. Identification of miRNAs Differentially Expressed in Human Epilepsy with or without Granule Cell Pathology
  33. Olfactory Neuroblastoma and Olfactory Ventricle
  34. Tailored pharmacoresistance related to underlying structural lesions
  35. Osseous Metaplasia and Mature Bone Formation With Extramedullary Hematopoiesis in Trichilemmal Cyst
  36. MGMT promoter methylation status in clival chordoma
  37. Letter to the Editor: Medial temporal epilepsy
  38. Letter to the Editor: Anterior temporal lobectomy
  39. Commentary on Cavernoma-related epilepsy: Review and recommendations for management-Report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies
  40. Failures in Temporal Lobe Epilepsy Surgery
  41. Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis
  42. Mutant BRAF in low‐grade epilepsy‐associated tumors and focal cortical dysplasia
  43. Epilepsy associated tumors: Review article
  44. A Proposed New Index for Clinical Evaluation of Interproximal Soft Tissues: The Interdental Pressure Index
  45. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III
  46. Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme
  47. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior
  48. Epilepsy in primary cerebral tumors: The characteristics of epilepsy at the onset (results from the PERNO study – Project of Emilia Romagna Region on Neuro‐Oncology)
  49. Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number
  50. Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications
  51. Seizure outcome of surgical treatment of focal epilepsy associated with low-grade tumors in children
  52. Neurogenesis in temporal lobe epilepsy: Relationship between histological findings and changes in dentate gyrus proliferative properties
  53. Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference
  54. Podoplanin and E-cadherin Expression in Preoperative Incisional Biopsies of Oral Squamous Cell Carcinoma Is Related to Lymph Node Metastases
  55. Epithelioid Angiosarcoma of the Septum Pellucidum
  56. A classification tree approach for pituitary adenomas
  57. Focal epilepsy associated with dysembryoplastic neuroepithelial tumor in the area of the caudate nucleus
  58. Relationship between focal cortical dysplasia and epilepsy-associated low-grade tumors: an immunohistochemical study
  59. Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias
  60. miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR
  61. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion
  62. Costal metastasis: A singular localization of gastrointestinal carcinoid tumor
  63. Commentary on the new ILAE classification system for focal cortical dysplasias
  64. Reelin: a possible link between hippocampal sclerosis and cortical dyslamination in the setting of FCD type IIIa
  65. Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma
  66. Immunoproteasome expression is induced in mesial temporal lobe epilepsy
  67. Treatment of pituitary neoplasms with temozolomide
  68. Commentary on patterns of hippocampal sclerosis as predictors of postsurgical outcome
  69. The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma
  70. Temporo-mesial extraventricular neurocytoma and cortical dysplasia in focal temporal lobe epilepsy
  71. Ex vivo study of dentate gyrus neurogenesis in human pharmacoresistant temporal lobe epilepsy
  72. Oligodendroglial hamartoma: a potential source of misdiagnosis for oligodendroglioma
  73. Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
  74. O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications
  75. Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection
  76. Thyrotropin-secreting pituitary tumours: significance of "atypical adenomas" in a series of 10 patients and association with Hashimoto thyroiditis as a cause of delay in diagnosis
  77. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20
  78. Ganglioneurocytoma of the spinal cord: report of a case and review of literature
  79. E‐cadherin loss and ΔNp73L expression in oral squamous cell carcinomas showing aggressive behavior
  80. Combined endoscopy-assisted cranionasal approach for resection of infantile myofibromatosis of the ethmoid and anterior skull base
  81. Late presentation of leucoencephalopathy with calcifications and cysts: report of two cases
  82. Co-existence of cavernoma and cortical dysplasia in temporal lobe epilepsy
  83. Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome
  84. Oncocytic Meningioma: Report of a Case With Progression After Radiosurgery
  85. Epithelioid Hemangioendothelioma of the Spinal Cord
  86. High ΔN p63 isoform expression favours recurrences in odontogenic keratocyst—odontogenic keratocystic tumour
  87. Merkel Cells in the Oral Mucosa
  88. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast
  89. Meningioangiomatosis involving the wall of the middle cerebral artery
  90. Polymorphous adenocarcinoma of the breast. Report of three cases
  91. Pigmented Mucoepidermoid Carcinoma of the Oral Cavity: A Case Report
  92. Basaloid carcinoma of the pancreas
  93. Peripheral ameloblastoma with Merkel cells
  94. Intraepidermal cells of paget’s carcinoma of the breast can be genetically different from those of the underlying carcinoma
  95. Fibrinogen storage disease without hypofibrinogenaemia associated with acute infection
  96. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation
  97. Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description
  98. Gemcitabine-associated CD8+ CD30+ pseudolymphoma.